IRMD: financial statements from SEC

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	22M	21M	20M	20M	18M	18M
Cost of revenue	5M	5M	4M	5M	4M	4M
Gross profit	17M	16M	16M	15M	14M	14M
Research and development	956,000	674,362	877,362	624,245	639,467	801,129
Selling, general and administrative	5M	4M	4M	5M	4M	4M
Operating expenses	10M	10M	9M	9M	8M	8M
Operating income	7M	7M	7M	5M	6M	6M
Pre-tax income	8M	7M	7M	6M	6M	6M
Income tax	2M	2M	2M	1M	1M	1M
Net income	6M	6M	6M	5M	5M	5M
Earnings per share	0.46	0.44	0.45	0.37	0.40	0.39
Earnings per share, diluted	0.45	0.43	0.45	0.37	0.40	0.38
Weighted average shares	13M	13M	13M	13M	13M	13M
Weighted average shares, diluted	13M	13M	13M	13M	13M	13M

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	56M	51M	57M	53M	50M	52M	52M	49M
Receivables	13M	14M	14M	11M	13M	11M	10M	12M
Inventory	12M	12M	12M	11M	11M	10M	11M	12M
Current assets	86M	81M	85M	77M	75M	75M	74M	74M
Property, plant and equipment	24M	24M	24M	23M	20M	17M	14M	10M
Total assets	114M	109M	115M	106M	102M	98M	94M	90M
Current liabilities	12M	10M	13M	9M	8M	9M	8M	7M
Total liabilities	16M	14M	16M	12M	12M	12M	11M	10M
Equity	99M	95M	98M	94M	90M	87M	83M	80M
Shares outstanding	13M	13M	13M	13M	13M	13M	13M	13M
Shares issued	13M	13M	13M	13M	13M	13M	13M	13M

Metric	31/03/2026	31/03/2025
Operating cash flow	8M	4M
Depreciation and amortisation	455,000	194,122
Share-based compensation	684,000	826,064
Capital expenditure	403,000	4M
Investing cash flow	−469,000	−4M
Dividends paid	3M	2M
Financing cash flow	−3M	−2M